FDA clears test that guides surgical decision-making in ovarian cancer
Sept 14, 2009
The FDA announced on Friday the clearance of a test that helps to detect ovarian cancer in a pelvic mass already known to require surgery. The OVA1 test helps patients and health care professionals decide the type of surgery and who should perform the surgery, according to an FDA press release.
Asked by Anonymous at 10:32 AM on Sep. 14, 2009 in Politics & Current Events
Answer by Sisteract at 10:40 AM on Sep. 14, 2009